Isorhamnetin Reduces Glucose Level, Inflammation, and Oxidative Stress in High-Fat Diet/Streptozotocin Diabetic Mice Model
Molecules · 04.01.2023 · 28 (2) · 502
DOI: 10.3390/molecules28020502 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, online erschienen am 04.01.2023. Verfasst von Abdelrahim Alqudah und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacy and Pharmacy Practice, Faculty of Pharmaceutical Sciences, The Hashemite University, Zarqa 13133, Jordan. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Insulin Resistance, Diabetes Mellitus, Experimental. Die Arbeit wurde bisher 60-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hashemite University, Deanship of Scientific Research at Hashemite University.
Abstract (Originalsprache)
Background
Isorhamnetin is a flavonoid that is found in medical plants. Several studies showed that isorhamnetin has anti-inflammatory and anti-obesity effects. This study aims to investigate the anti-diabetic effects of isorhamnetin in a high-fat diet and Streptozotocin-(HFD/STZ)-induced mice model of type 2 diabetes. Materials and Methods: Mice were fed with HFD followed by two consecutive low doses of STZ (40 mg/kg). HFD/STZ diabetic mice were treated orally with isorhamnetin (10 mg/kg) or (200 mg/kg) metformin for 10 days before sacrificing the mice and collecting plasma and soleus muscle for further analysis.
Results
Isorhamnetin reduced the elevated levels of serum glucose compared to the vehicle control group (p < 0.001). Isorhamnetin abrogated the increase in serum insulin in the treated diabetic group compared to the vehicle control mice (p < 0.001). The homeostasis model assessment of insulin resistance (HOMA-IR) was decreased in diabetic mice treated with isorhamnetin compared to the vehicle controls. Fasting glucose level was significantly lower in diabetic mice treated with isorhamnetin during the intraperitoneal glucose tolerance test (IPGTT) (p < 0.001). The skeletal muscle protein contents of GLUT4 and p-AMPK-α were upregulated following treatment with isorhamnetin (p > 0.01). LDL, triglyceride, and cholesterol were reduced in diabetic mice treated with isorhamnetin compared to vehicle control (p < 0.001). Isorhamnetin reduced MDA, and IL-6 levels (p < 0.001), increased GSH levels (p < 0.001), and reduced GSSG levels (p < 0.05) in diabetic mice compared to vehicle control.
Conclusions
Isorhamnetin ameliorates insulin resistance, oxidative stress, and inflammation. Isorhamnetin could represent a promising therapeutic agent to treat T2D.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Pharmacy and Pharmacy Practice, Faculty of Pharmaceutical Sciences, The Hashemite University, Zarqa 13133, Jordan.
- Department of Biology and Biotechnology, Faculty of Science, The Hashemite University, Zarqa 13133, Jordan.
- Department of Pharmaceutical Technology, Faculty of Pharmaceutical Sciences, The Hashemite University, Zarqa 13133, Jordan.
- Department of Physiology, College of Medicine and Medical Sciences, Arabian Gulf University, Manama 329, Bahrain.
- Department of Physiology and Biochemistry, College of Medicine, Jordan University of Science and Technology, Irbid 22110, Jordan.
- Department of Medical Laboratory Sciences, Faculty of Allied Science, Zarqa University, Zarqa 13133, Jordan.
ORCID-Profile: Abdelrahim Alqudah, Esam Y Qnais, Khaled Alrosan, Mohammad Alqudah
Förderung
- Hashemite University
- Deanship of Scientific Research at Hashemite University
Zitieren
APA
Alqudah, A., Qnais, E. Y., Wedyan, M. A., Altaber, S., Bseiso, Y., Oqal, M., AbuDalo, R., Alrosan, K., Alrosan, A. Z., Bani Melhim, S., Alqudah, M., Athamneh, R. Y., & Gammouh, O. (2023). Isorhamnetin Reduces Glucose Level, Inflammation, and Oxidative Stress in High-Fat Diet/Streptozotocin Diabetic Mice Model. Molecules, 28(2), 502. https://doi.org/10.3390/molecules28020502
Vancouver
Alqudah A, Qnais EY, Wedyan MA, Altaber S, Bseiso Y, Oqal M, et al. Isorhamnetin Reduces Glucose Level, Inflammation, and Oxidative Stress in High-Fat Diet/Streptozotocin Diabetic Mice Model. Molecules. 2023;28(2):502. doi:10.3390/molecules28020502
BibTeX
@article{Alqudah2023,
author = {Alqudah, Abdelrahim and Qnais, Esam Y and Wedyan, Mohammed A and Altaber, Sara and Bseiso, Yousra and Oqal, Muna and AbuDalo, Rawan and Alrosan, Khaled and Alrosan, Amjad Z and Bani Melhim, Suhad and Alqudah, Mohammad and Athamneh, Rabaa Y and Gammouh, Omar},
title = {Isorhamnetin Reduces Glucose Level, Inflammation, and Oxidative Stress in High-Fat Diet/Streptozotocin Diabetic Mice Model},
journal = {Molecules},
year = {2023},
volume = {28},
number = {2},
pages = {502},
doi = {10.3390/molecules28020502}
}
EUVIMED